Upcoming Reports [full schedule to be confirmed]

Schedule of Publications 2023

2023

Nov

  • Launch of 2023-2024 survey

    New Survey 2023

Oct

  • Neurological Edition [with Multiple Sclerosis]

    Corporate Reputation of Pharma 2022

  • Environmental, Social & Governance Report

    New Survey 2023

Sep

  • Arthritis Edition

    Corporate Reputation of Pharma 2022

  • Mental Health Edition

    Corporate Reputation of Pharma 2022

    Published

  • Spain Edition

    Corporate Reputation of Pharma 2022

    Published

Aug

  • Ukraine Report

    New Survey 2023

    Published

  • Rare Diseases Edition [with Bleeding Disorders]

    Corporate Reputation of Pharma 2022

    Published

  • Australia, New Zealand, China and Japan Edition

    Corporate Reputation of Pharma 2022

    Published

Jul

  • Respiratory Edition

    Corporate Reputation of Pharma 2022

    Published

  • France Edition

    Corporate Reputation of Pharma 2022

    Published

Jun

  • Italy Edition

    Corporate Reputation of Pharma 2022

    Published

  • Germany Edition

    Corporate Reputation of Pharma 2022

    Published

  • Cancer Edition

    Corporate Reputation of Pharma 2022

    Published

May

  • Canada Edition

    Corporate Reputation of Pharma 2022

    Published

  • UK Edition

    Corporate Reputation of Pharma 2022

    Published

  • USA Edition

    Corporate Reputation of Pharma 2022

    Published

Apr

  • Global Edition

    Corporate Reputation of Pharma 2022

    Published

2022

Nov

  • Mental Health Edition

    Corporate Reputation of Pharma 2021

    Published

  • Neurological Edition

    Corporate Reputation of Pharma 2021

    Published

Oct

  • Autoimmune Edition

    Corporate Reputation of Pharma 2021

    Published

  • Respiratory Edition

    Corporate Reputation of Pharma 2021

    Published

Sep

  • Rare Diseases Edition (with Bleeding Disorders subanalyses)

    Corporate Reputation of Pharma 2021

    Published

  • Italy Edition

    Corporate Reputation of Pharma 2021

    Published

  • Spain Edition

    Corporate Reputation of Pharma 2021

    Published

Aug

  • Asia Edition

    Corporate Reputation of Pharma 2021

    Published

  • Germany Edition

    Corporate Reputation of Pharma 2021

    Published

Jul

  • UK Edition

    Corporate Reputation of Pharma 2021

    Published

  • France Edition

    Corporate Reputation of Pharma 2021

    Published

Jun

  • ESG report

    Corporate Reputation of Pharma 2021

    Published

  • Canada Edition

    Corporate Reputation of Pharma 2021

    Published

  • HIV/AIDS Edition

    Corporate Reputation of Pharma 2021

    Published

May

  • MAIN Cancer [including subanalyses]

    Cancer Edition, Corporate Reputation of Pharma 2021

    Published

  • USA Edition

    Corporate Reputation of Pharma 2021

    Published

Apr

  • Global Edition

    Corporate Reputation of Pharma 2021

    Published

Up